Dec 01, 2022 / 02:30PM GMT
Christopher Joseph Raymond - Piper Sandler & Co., Research Division - MD & Senior Research Analyst
Okay. We're going to go ahead and get started. Thanks, everybody, for being here for day 3 of the Piper Sandler Healthcare Conference. My name is Chris Raymond. I'm one of the biotech analysts here at Piper Sandler. Very pleased to have with us our next company, which needs no introduction is AbbVie, of course, I have with me the Vice Chairman and President, to my left, Rob Michael, Jeff Stewart, EVP and Chief Commercial Officer; Tom Hudson, who is the Chief Scientific Officer; and Scott Reents, CFO.
So we have a full complement of management here for our talk. So normally, we ask companies to give a 2- or 3-minute overview on the company. I don't think we need to sort of go into that. So maybe we'll just dive into Q&A.
And this is a fireside chat format meant to be very informal. If anybody has any questions, please raise your hand. I'll make sure it gets asked and answered effectively. So thanks again for being here.
Robert A. Michael - AbbVie Inc
Abbvie Inc at Piper Sandler Healthcare Conference Transcript
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot